All Pharma News
JSR Life Sciences Announces Operational Consolidation of KBI Bio and Selexis

JSR Life Sciences Announces Operational Consolidation of KBI Bio and Selexis
BUSINESSWIRE
31 May 2023
Share Share
Crown Bioscience Opens Singapore Lab, Partners with JSR Life Sciences

Crown Bioscience Opens Singapore Lab, Partners with JSR Life Sciences
CONTRACT PHARMA
10 Mar 2023
Share Share
Similis Bio Partners With Novel351k to Develop Multiple Biosimilar Programs

Similis Bio Partners With Novel351k to Develop Multiple Biosimilar Programs
CONTRACT PHARMA
15 Feb 2023
Share Share
Crown Bioscience inks deal with ERS for gene editing technology

Crown Bioscience inks deal with ERS for gene editing technology
Joseph Keenan FIERCEBIOTECH
12 Dec 2022
Share Share
JSR Life Sciences Launches `Similis Bio` for Biosimilar Development

JSR Life Sciences Launches `Similis Bio` for Biosimilar Development
BUSINESSWIRE
10 May 2022
Share Share
JSR Life Sciences Appoints Mark W. Womack to Lead KBI Biopharma and Selexis SA

JSR Life Sciences Appoints Mark W. Womack to Lead KBI Biopharma and Selexis SA
BUSINESSWIRE
02 May 2022
Share Share
KBI Biopharma Opens New Commercial Manufacturing Facility

KBI Biopharma Opens New Commercial Manufacturing Facility
CONTRACTPHARMA
21 Apr 2022
Share Share
JSR Life Sciences’ Amsphere A3 Leveraged in FDA-Approved Antibody Therapy

JSR Life Sciences’ Amsphere A3 Leveraged in FDA-Approved Antibody Therapy
CONTRACTPHARMA
21 Mar 2022
Share Share
Hemogenyx, Selexis Will Advance AML CDX Bispecific Antibody to Human Trials

Hemogenyx, Selexis Will Advance AML CDX Bispecific Antibody to Human Trials
BUSINESSWIRE
12 Jan 2022
Share Share
Crown Bioscience Launches ‘3D Ex Vivo Patient Tissue Platform’

Crown Bioscience Launches ‘3D Ex Vivo Patient Tissue Platform’
BUSINESSWIRE
07 Oct 2021
Share Share